MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Stroh, Jacob (Author) , Seckinger, Anja (Author) , Heider, Michael (Author) , Rudelius, Martina (Author) , Eichner, Ruth (Author) , Schick, Markus (Author) , Slawska, Jolanta (Author) , Emde-Rajaratnam, Martina (Author) , Salwender, Hans (Author) , Bertsch, Uta (Author) , Goldschmidt, Hartmut (Author) , Weisel, Katja (Author) , Scheid, Christoph (Author) , Keller, Ulrich (Author) , Hose, Dirk (Author) , Bassermann, Florian (Author)
Format:	Article (Journal)
Language:	English
Published:	18 January 2022
In:	Blood advances Year: 2022, Volume: 6, Issue: 2, Pages: 515-520
ISSN:	2473-9537
DOI:	10.1182/bloodadvances.2021005532
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/bloodadvances.2021005532
Author Notes:	Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde-Rajaratnam, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja Weisel, Cristof Scheid, Ulrich Keller, Dirk Hose, and Florian Bassermann

Early response to first-line anti-PD-1 treatment in Hodgkin lymphoma: a PET-based analysis from the prospective, randomized phase II NIVAHL trial by Voltin, Conrad-Amadeus (Author) , Mettler, Jasmin (Author) , Heek, Lutz van (Author) , Goergen, Helen (Author) , Müller, Horst (Author) , Baues, Christian (Author) , Keller, Ulrich (Author) , Meißner, Julia (Author) , Trautmann-Grill, Karolin (Author) , Kerkhoff, Andrea (Author) , Fuchs, Michael (Author) , Sasse, Stephanie (Author) , Tresckow, Bastian von (Author) , Dietlein, Markus (Author) , Borchmann, Peter (Author) , Engert, Andreas (Author) , Kobe, Carsten (Author) , Bröckelmann, Paul J. (Author) ,

in: Clinical cancer research, 27 (2021), 2, Seite 402-407

Article (Journal) Online Resource